Investing in the Weight-Loss Sector Surge
Speaker: Yeo Sze Han
Date: 13 June 2024
While AI stocks have dominated news headlines and market interest for the past two years, a less-discussed class of non-AI stocks has quietly delivered impressive returns (and trimmed waistlines) during the same period. Ozempic, Wegovy, Zepbound, and Mounjaro are some of the weight-loss drugs that have been making waves on social media and in the stock markets due to their seemingly magical ability to help high-profile celebrities and influencers shed weight and keep the pounds off, quickly and effortlessly. But are these miracle drugs (and their stock returns) as good as they are promised by the pharmaceutical companies? Join us for a one-hour webinar as we explore the theme of weight-loss stocks, examine if there is meat behind the hype, and discuss whether you should consider adding them to your portfolio.
This webinar will cover:
✅ Weight-loss sector overview and outlook
✅ Weight-loss stocks analysis
Date: 13 June 2024
While AI stocks have dominated news headlines and market interest for the past two years, a less-discussed class of non-AI stocks has quietly delivered impressive returns (and trimmed waistlines) during the same period. Ozempic, Wegovy, Zepbound, and Mounjaro are some of the weight-loss drugs that have been making waves on social media and in the stock markets due to their seemingly magical ability to help high-profile celebrities and influencers shed weight and keep the pounds off, quickly and effortlessly. But are these miracle drugs (and their stock returns) as good as they are promised by the pharmaceutical companies? Join us for a one-hour webinar as we explore the theme of weight-loss stocks, examine if there is meat behind the hype, and discuss whether you should consider adding them to your portfolio.
This webinar will cover:
✅ Weight-loss sector overview and outlook
✅ Weight-loss stocks analysis
